SRTA (Strata Critical Medical) Pretax Margin %: 3.56% (As of Mar. 2026)


SRTA Strata Critical Medical Inc SRTA
70 GF Score
Price $5.30
GF Value $4.47
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Strata Critical Medical Pretax Margin %?

Strata Critical Medical SRTA -1.21% 70 Pretax Margin % is 3.56% as of Mar. 2026. GuruFocus rates SRTA with a GF Score™ of 70/100 and a GF Value™ of $4.47 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Strata Critical Medical ranks worse than 72.78% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Strata Critical Medical's Pre-Tax Income for the three months ended in Mar. 2026 was $2.4 Mil. Strata Critical Medical's Revenue for the three months ended in Mar. 2026 was $67.4 Mil. Therefore, Strata Critical Medical's pretax margin for the quarter that ended in Mar. 2026 was 3.56%.

The historical rank and industry rank for Strata Critical Medical's Pretax Margin % or its related term are showing as below:

SRTA' s Pretax Margin % Range Over the Past 10 Years
Min: -86.48   Med: -25.55   Max: -6.44
Current: -6.44


SRTA's Pretax Margin % is ranked worse than
72.78% of 665 companies
in the Healthcare Providers & Services industry
Industry Median: 4 vs SRTA: -6.44

Strata Critical Medical  (NAS:SRTA) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Strata Critical Medical Pretax Margin % Related Terms


Strata Critical Medical Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Strata Critical Medical's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Strata Critical Medical Pretax Margin % Chart

Strata Critical Medical Annual Data
Trend Sep19 Sep20 Sep21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
Get a 7-Day Free Trial -86.48 -19.18 -25.55 -11.01 -10.18

Strata Critical Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.48 -5.26 -19.59 -8.07 3.56

SRTA vs TOI, GMRS, CCRN: Pretax Margin % Comparison

For the Medical Care Facilities subindustry, Strata Critical Medical's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Strata Critical Medical Pretax Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Strata Critical Medical's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Strata Critical Medical's Pretax Margin % falls into.


SRTA
70GF Score
Strata Critical Medical Inc SRTA
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Strata Critical Medical Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Strata Critical Medical's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-20.066/197.141
=-10.18 %

Strata Critical Medical's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=2.402/67.384
=3.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of 3.56% mean?
Strata Critical Medical (SRTA) has a Pretax Margin % of 3.56% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Strata Critical Medical and its competitors. According to the industry distribution chart, Strata Critical Medical ranks #484 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 72.8%.
Is Strata Critical Medical's Pretax Margin % too high?
Strata Critical Medical's current Pretax Margin % is 3.56%. The Healthcare Providers & Services industry median Pretax Margin % is 4.00. Strata Critical Medical's value of 3.56% is 11% below this industry median. Based on the distribution chart, Strata Critical Medical ranks #484 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Strata Critical Medical has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Strata Critical Medical's Pretax Margin % compare to TOI and GMRS?
According to the Healthcare Providers & Services industry distribution chart, Strata Critical Medical ranks #484 out of 665 companies for Pretax Margin %. This places Strata Critical Medical in the lower half of its industry. The industry median Pretax Margin % is 4.00. Strata Critical Medical's value of 3.56% is 11% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.00, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Strata Critical Medical's current Pretax Margin % of 3.56% is 11% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Strata Critical Medical and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strata Critical Medical's current Pretax Margin % is 3.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Critical Medical stock overvalued right now?
Based on GuruFocus' analysis, Strata Critical Medical (SRTA) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.47, compared to a current price of $5.30 — trading 18.5% above its estimated fair value. The current Pretax Margin % is 3.56% and 11% below the Healthcare Providers & Services industry median of 4.00. Strata Critical Medical's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Strata Critical Medical (SRTA), the current Pretax Margin % is 3.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Strata Critical Medical (SRTA) Overvalued in 2026?

Based on GuruFocus' analysis, Strata Critical Medical stock appears to be overvalued. The current stock price of $5.30 is trading 18.5% above its estimated GF Value™ of $4.47. GuruFocus considers Strata Critical Medical to be Modestly Overvalued.

Key valuation signals for SRTA:

  • Pretax Margin %: 3.56%
  • GF Value™: $4.47 vs. price of $5.30 (18.5% above fair value)
  • GF Score™: 70/100 with 4 warning signs
  • Industry Position: 11% below the Healthcare Providers & Services median (#484 of 665)

No single metric tells the full story. See the SRTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Strata Critical Medical Business Description

Address 31 Hudson Yards, 14th Floor, New York, NY, USA, 10001
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
70GF Score

Get the complete analysis for SRTA

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.30
Price
$4.47
GF Value